Pharmaceuticals Businesses for Sale and Investment Opportunities

- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

- API manufacturing unit in Telangana operational for the last 4 years. - This is a USFDA and EU regulation-compliant manufacturing facility. - The factory is used for contract manufacturing of APIs. - The buyer gets all the tangible and intangible assets of the factory.

- Pharmaceutical manufacturing and marketing company based in Dhaka. - Company markets and sells the products under its own brand. - Have 54 approved drugs including oncology, ARV, CNS, bone care, and hormone products. - Company has its own manufacturing unit with a maximum production capacity of 750 million pieces per year. - Products are sold through 26 local distributors and 3 international distributors for Europe, Asia, and Africa.

- The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin. - The company can sell also in the private market which has a 40% profit margin. - Own 9.25-acre land valued at USD 1mln approx. - The license is issued and a government buyback agreement is signed. - The project is in plug and play stage where the investor can mobilize immediately. - Commercial manufacturing can commence in 8 months.

- API manufacturing company based in Indore, India. For the past 3 decades, this company has focused on API development, manufacturing, and marketing of APIs and intermediates. It has a state-of-the-art manufacturing facility and is a state GMP-certified plant facility. - This is a research-driven organization – that develops technology, translates it to production, and then delivers it to customers. With a strong commitment to excellence in product quality (which is never compromised) and adherence to strict delivery schedules, they are presently exporting to 14 countries around the world. - The company’s strength lies in providing extended support to its customers. Their success has been validated by what they hold the dearest – product excellence and customer service. The company believes that long-term business is rooted in values and business ethics. - It is one of the leading manufacturers of Tinidazole and Ornidazole, which are considered anti-protozoal molecules, a segment of bulk drugs. Sales have shown an increasing trend. - The company has received Good Manufacturing Practices (GMP) Certificate from the Office of the Controller of Food and Drugs Administration, Madhya Pradesh. Note: this transaction is being handled by an advisory firm based in Rajkot.

- Leading IV fluid manufacturer with cutting-edge machinery for superior quality. - Impressive manufacturing capacity: - Maximum production: 10 lakhs bottles/day. - Average production: 8 lakhs/day. - 5 years of invaluable industry experience. - Trusted suppliers from Gujarat, Bombay, and Delhi (10 in total). - Extensive B2B distribution network with 35 partners covering the entire northern region. - Compliant with WHO-GMP standards, ensuring product excellence. - The company is breaking even at the moment.

- Great facility with GMP & ISO certification. - Stalwart in the veterinary business. - Over 40 trademarked products. - Pan India presence with 150 employees and 21 distributors. - Sale would include full business. - The business started operations 35 years ago and was incorporated 14 years ago.

- Pharmaceutical manufacturer of generic capsules, tablets, and soft gels. - Manufacturing facility was recently completed and is located on 30,000 sq. m. of owned land. - Annual production capacity of 117 million capsules, 205 million tablets, and 313 million soft gels. - Business has not recorded any sales yet. - Will cater to MENA and the export market as well. - The investor will receive a maximum stake of 51% in the company that owns this manufacturing facility.

- Colombian pharmaceutical company that has been operational for close to 20 years. - We have developed 30 medicines registered with INVIMA under our own brand names. - Products are produced by 6 contract manufacturers in Colombia. - We sell the products to doctors and distributors. - Have 6 big distributors who sell to official entities and over 1,200 doctors prescribe our products regularly in a very well organized CRM.